Global Coalition for Adaptive Research

About Global Coalition for Adaptive Research

The Global Coalition for Adaptive Research (GCAR) is dedicated to transforming the clinical trial landscape. By developing Master Protocols and Adaptive Platform Trials, GCAR fosters collaboration among clinicians, researchers, and industry partners to expedite the discovery of treatments for rare and deadly diseases.

Impact

GCAR's initiatives focus on improving patient outcomes for conditions like glioblastoma and ovarian cancer, ensuring that effective therapies reach those in need more swiftly.

Why Donate?

Your contributions to GCAR support groundbreaking clinical trials that can lead to significant advancements in treatment for patients facing rare and deadly diseases.

Get Involved

Join the fight against rare diseases by donating today. Your support can help revolutionize the clinical trial process and bring hope to countless patients.